Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹1,996.50down ₹14.50 (0.72%)BSE ₹1,996.55
Share price at the NSE close on 2 Nov 2026. Previous close ₹2,011.00.
2 Nov: open ₹2,019.80, high ₹2,033.80, low ₹1,996.50
52-week range of traded prices to 2 Nov 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,298 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.51
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.00
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,64,79862.6% delivered
Lupin share news and announcements
2,114 announcements, routine notices left out, newest first. Page 34 of 43.
May 2013
8 May · Results
Standalone Results for the year ended on 31-MAR-2013 as follows: Net Sales of Rs. 701049 lacs for year ending on 31-MAR-2013 against Rs. 531589 lacs for the year ending on 31-MAR-2012. Net Profit / (Loss) of Rs. 126043 lacs for the year ending on 31-MAR-2013 against Rs. 80437 lacs for the year ending on 31-MAR-2012.8 May · Results
Standalone Results for the quarter ended on 31-MAR-2013 as follows: Net Sales of Rs. 157937 lacs for the quarter ending on 31-MAR-2013 against Rs. 195866 lacs and Rs. 144298 lacs for the quarters ending on 31-DEC-2012 and 31-MAR-2012 respectively. Net Profit / (Loss) of Rs. 13296 lacs for the quarter ending on 31-MAR-2013 against Rs. 44830 lacs and Rs. 24889 lacs for the quarters ending on 31-DEC-2012 and 31-MAR-2012 respectively.8 May · Dividend
Board of Directors of the Company at its meeting held on May 08, 2013 has recommended dividend @ 200% i.e. Rs.4/- per equity share of the face value of Rs.2/- each for the year ended March 31, 2013.
Apr 2013
29 Apr · Board meeting
Inter alia, to consider stand-alone and consolidated annual audited financial results for the year ended March 31, 2013 and recommend dividend, if any.23 Apr · Business
Allotment Committee of Directors at its meeting held on April 23, 2013 has allotted 107609 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs.89,52,74,204 consisting 44,76,37,102 equity shares of Rs. 2/- each.
Mar 2013
18 Mar · Business
Allotment Committee of Directors at its meeting held on March 18, 2013 has allotted 33603 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs.89,50,58,986 consisting 44,75,29,493 equity shares of Rs. 2/- each.13 Mar · Disclosure
Company has granted 7200 options to the employee of its subsidiary company, under "Lupin Subsidiary Companies Employees Stock Option Plan 2011" at the exercise price of Rs. 600.90 on March 12, 2013. Further, the Company has informed the Exchange that one equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
Feb 2013
22 Feb · Disclosure
Company has granted 9500 options to its employee, under "Lupin Employees Stock Option Plan 2005" and 118800 options to the employees of its subsidiary companies, under "Lupin Subsidiary Companies Employees Stock Option Plan 2011" at the exercise price of Rs. 593.90 on February 22, 2013. Further, the Company has informed the Exchange that one equity share of Rs. 2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.8 Feb · Business
Allotment Committee of Directors at its meeting held on February 08, 2013 has allotted 30464 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs.89,49,91,780 consisting 44,74,95,890 equity shares of Rs. 2/- each.
Jan 2013
31 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2012 as follows: Net Sales of Rs. 195866 lacs for the quarter ending on 31-DEC-2012 against Rs. 170882 lacs and Rs. 139176 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively. Net Profit / (Loss) of Rs. 44830 lacs for the quarter ending on 31-DEC-2012 against Rs. 32194 lacs and Rs. 21461 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively.31 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2012 as follows: Net Sales of Rs. 246587 lacs for the quarter ending on 31-DEC-2012 against Rs. 223926 lacs and Rs. 179170 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively. Net Profit / (Loss) of Rs. 33523 lacs for the quarter ending on 31-DEC-2012 against Rs. 29046 lacs and Rs. 23506 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively.16 Jan · Business
Allotment Committee of Directors at its meeting held on January 16, 2013 has allotted 51226 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs.89,49,30,852 consisting 44,74,65,426 equity shares of Rs. 2/- each.15 Jan · Board meeting
Inter alia, to consider and take on record unaudited financial results for the quarter ended December 31, 2012.
Dec 2012
3 Dec · Business
Allotment Committee of Directors at its meeting held on December 03, 2012 has allotted 27319 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs.89,48,28,400 consisting 44,74,14,200 equity shares of Rs. 2/- each.
Nov 2012
7 Nov · Disclosure
On November 07, 2012 the Company has granted 50000 options to its employee under '"Lupin Employees Stock Option Plan 2005'" at an exercise price of Rs. 291.93 on November 06, 2012. Further, the Company has informed the Exchange that one equity share of Rs. 2/- each is covered by each option. The options granted are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.2 Nov · Business
Allotment Committee of Directors at its meeting held on November 02, 2012 has allotted 186044 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs.89,47,73,762 consisting 44,73,86,881 equity shares of Rs. 2/- each.
Oct 2012
23 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 23, 2012 has : (1) Appointed Mr. Dileep C. Choksi as Additional Director (2) Appointed Mr. Dileep C. Choksi as Members of the Audit Committee (3) Appointed Dr. Vijay Kelkar as Chairman of the Investors Grievances Committee and (4) noted and took on record the resignation of Mr. D. K. Contractor from the directorship of the Company on health grounds.23 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2012 as follows: Net Sales of Rs. 170882 lacs for the quarter ending on 30-SEP-2012 against Rs. 176364 lacs and Rs. 138691 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively. Net Profit / (Loss) of Rs. 32194 lacs for the quarter ending on 30-SEP-2012 against Rs. 35723 lacs and Rs. 26812 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively.18 Oct · Disclosure
On October 17, 2012 the Company has granted 5000 options to its employee under "Lupin Employees Stock Option Plan 2011" at an exercise price of Rs. 555.55. Further, one equity share of Rs. 2/- each is covered by each option. The options granted are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.